Current Hepatitis News
News
- April 02, 2013 | Berkeley Patch
American Liver Foundation to Honor Berkeley Woman
Dr. Carol L. Brosgart, VHAC Senior Advisor on Science and Policy, will be honored April 13th at the American Liver Foundation’s Salute to Excellence Awards Gala for her commitment to battling viral hepatitis.
Read Article > - March 20, 2013 | National Alliance of State and Territorial AIDS Directors (NASTAD)
The Affordable Care Act and the Silent Epidemic: Increasing the Viral Hepatitis Response Through Health Reform
The National Alliance of State and Territorial AIDS Directors examines the Affordable Care Act and opportunities for a response to viral hepatitis.
Read Paper > - March 15, 2013 | Financial Times
Hepatitis C: the cure?
This article outlines the history of hepatitis C, as well as current and future treatment options.
Read Article > - March 11, 2013 | blog.AIDS.gov
Conversations from CROI 2013: CDC’s Dr. John Ward
Viral hepatitis was discussed at the recent 2013 Conference on Retroviruses and Opportunistic Infections.
Read Article > - March 07, 2013 | Hepatology
Potential consequences of healthcare recommendations: A focus on the USPSTF
The authors argue that the USPSTF’s recommendations have far-reaching consequences for public health, using the recent CDC hepatitis cohort testing recommendations as a study.
Read Article > - March 05, 2013 | Annals of Internal Medicine
Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma
This article analyzes various observational studies to determine the association between response to hepatitis C therapy and development of hepatocellular carcinoma in certain populations.
Read Article > - March 04, 2013 | Wall Street Journal
Patient Dilemma: Treat Hepatitis C Now or Hold Out?
A growing number of hepatitis C patients are putting off immediate treatment, electing to wait for a newer generation of less toxic drugs to become available.
Read Article > - February 15, 2013 | CDC MMWR
Completeness of Reporting of Chronic Hepatitis B and C Virus Infections — Michigan, 1995–2008
An evaluation of viral hepatitis surveillance in Michigan showed that reporting of chronic HBV and HCV infections was incomplete; however, reporting has improved over time. The findings suggest the need for additional data sources for risk factor information, especially because data in chronic viral hepatitis case reports might not reflect the current risk for secondary transmission.
Read Study > - February 12, 2013 | AIDS.gov Blog
Sounding the Alarm on a Silent Epidemic: Federal HIV/STD Advisory Group Adopts Viral Hepatitis as Priority
The CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC), recently decided to expand its mission scope to target viral hepatitis.
Read Article > - February 06, 2013 | Hepatology
The impact of timing and prioritisation on the cost-effectiveness of birth-cohort testing and treatment for hepatitis C virus in the U.S.
The cost-effectiveness of birth cohort testing for hepatitis C infection is examined, yielding a finding that the greatest return on investment is obtained with patients are treated immediately and those with advanced disease are prioritized.
Read Abract >